Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07433179
PHASE1
A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants
Sponsor: Septerna, Inc.
View on ClinicalTrials.gov
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effects of oral SEP-479 in healthy adult participants.
Official title: A Phase 1 Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SEP-479 in Healthy Adult Participants
Key Details
Gender
All
Age Range
21 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2026-03
Completion Date
2027-02
Last Updated
2026-02-25
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
SEP-479
Oral, capsule
OTHER
Placebo
Oral, capsule